Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reapplix APS

www.reapplix.com

Latest From Hangzhou Minsheng Pharmaceutical Group Co. Ltd.

Game Of Thrones: Bayer Looks To Lead China’s OTC Market

The recent acquisition of Dihon Pharmaceutical Group marks progress toward Bayer’s goal of becoming the leader in the OTC sector in China. Dihon provides an entry into the TCM arena, which makes up about half of the OTC segment in China, the firm says.

Consumer China

Game Of Thrones: Bayer Looks To Lead China’s OTC Market

After the recent acquisition of a local OTC firm, PharmAsia News takes a closer look at Bayer’s aims of becoming the leader in the OTC sector in China.

BioPharmaceutical China

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

China Earnings Overview: Sanofi’s OTC Slowdown, Bayer’s Glucobay Legendary Success

With China the main engine of growth for multinational drug firms in emerging markets, PharmAsia News takes a closer look at companies’ China earnings, finding some strong Q3 sales figures, but slowdowns for others.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Therapeutic Areas
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Reapplix APS
  • Senior Management
  • Niels E Holm, PhD, CEO
    Rasmus Lundquist, CSO
  • Contact Info
  • Reapplix APS
    Phone: 88 16 80 66
    Blokken 45
    Birkerød, 3460
    Denmark
Advertisement
Advertisement
UsernamePublicRestriction

Register